4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 85,090 | 90 | 15 | 14 | 1 |
| Gross Profit | 85,090 | 90 | 15 | 14 | 1 |
| Operating Expenses | 70,375 | 61,275 | 59,471 | 53,635 | 56,118 |
| Operating Income | 14,715 | -61,185 | -59,456 | -53,621 | -56,117 |
| Other Income | 4,682 | 4,309 | 4,798 | 5,649 | 6,446 |
| Pre-tax Income | 19,397 | -56,876 | -54,658 | -47,972 | -49,671 |
| Net Income Continuous | 19,397 | -56,876 | -54,658 | -47,972 | -49,671 |
| Net Income | $19,397 | $-56,876 | $-54,658 | $-47,972 | $-49,671 |
| EPS Basic Total Ops | 0.43 | -1.01 | -0.98 | -0.86 | -0.90 |
| EPS Basic Continuous Ops | 0.43 | -1.01 | -0.98 | -0.86 | -0.90 |
| EPS Diluted Total Ops | 0.43 | -1.01 | -0.98 | -0.86 | -0.90 |
| EPS Diluted Continuous Ops | 0.43 | -1.01 | -0.98 | -0.86 | -0.90 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.01 | -0.98 | -0.86 | -0.90 |
| EBITDA(a) | $14,784 | $-61,078 | $-59,456 | $-53,837 | $-56,871 |